Maternal prenatal depression and epigenetic age deceleration: testing potentially confounding effects of prenatal stress and SSRI use
Previous studies suggest epigenetic alterations may contribute to the association between maternal prenatal depression and adverse offspring outcomes. Developmental researchers have recently begun to examine these associations in relation to epigenetic age acceleration/deceleration, a biomarker of d...
Main Authors: | Brooke G. McKenna, Cassandra L. Hendrix, Patricia A. Brennan, Alicia K. Smith, Zachary N. Stowe, D. Jeffrey Newport, Anna K. Knight |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-03-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2020.1795604 |
Similar Items
-
Does prenatal exposure to antidepressants cause autism? - literature review
by: Zuzanna Marczyńska, et al.
Published: (2024-02-01) -
Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
by: Ramesa Shafi Bhat, et al.
Published: (2023-02-01) -
Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study
by: Allison L. Moreau, et al.
Published: (2023-04-01) -
Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice
by: Weonjin Yu, et al.
Published: (2019-04-01) -
Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
by: Åsa Edvinsson, et al.
Published: (2020-01-01)